Cardio-Hepatic Metabolic Derangements and Valproic Acid

E-ISSN： 2212-3938|9|2|165-170

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.9, Iss.2, 2014-05, pp. : 165-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid

By Chatzistefanidis Dimitrios Georgiou Ioannis Kyritsis Athanassios P Markoula Sofia

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1055-1071

Future Medicine

Access to resources Recommend Favorite

Paracetamol/valproic acid interaction: Acute hepatic injury resulting in clotting abnormalities in a child: case report

Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite

Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1427-1434

Bentham Science Publishers

Access to resources Recommend Favorite

Coagulation disorders with valproic acid in children

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Valproic acid: Encephalopathy: case report

Reactions Weekly, Vol. 1, Iss. 1128, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite